Key Financial Data Of Group

Oncolys BioPharma Inc. - Filing #7712397

Concept As at
2019-03-31
2019-01-01 to
2019-03-31
As at
2018-12-31
2018-01-01 to
2018-12-31
As at
2018-03-31
2018-01-01 to
2018-03-31
Key financial data of group
Business results of group
Net sales
48,383,000 JPY
168,549,000 JPY
33,874,000 JPY
Ordinary profit (loss)
-359,220,000 JPY
-1,230,105,000 JPY
-310,439,000 JPY
Net assets
2,612,972,000 JPY
2,901,153,000 JPY
2,596,831,000 JPY
Total assets
3,310,500,000 JPY
3,430,112,000 JPY
3,148,825,000 JPY
Basic earnings (loss) per share
-26.91
-104.55
-28.09
Diluted earnings per share
Equity-to-asset ratio
0.786 xbrli:pure
0.843 xbrli:pure
0.821 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.